NUTXNutex Health Inc.
Is the business good?
A genuinely good business: 7 of 9 health tests passed, earnings fully cash-backed (1.0×), and margins widening.
High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.
Operating profit is fully backed by cash. Conversion is improving vs a year ago.
Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.
Margin-driven, fat margins on slower asset turns. ROE 33% = margin × turnover × leverage.
Unless marked, from derived.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is NUTX?
Nutex Health Inc. keeps 43% of every revenue dollar as operating profit, against 9.3% for the median Medical Care Facilities name.
Operating margin · Medical Care Facilities median 9.3% · 12 months to Q2 2026
- Cash conversion
- 0.97×
Cash conversion · 0.45× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- +17%
Share count, year on year · shareholders own a smaller slice than a year ago
- Gross margin
- 51%
Gross margin
| Year | Operating margin |
|---|---|
| FY2020 | 56% |
| FY2021 | 51% |
| FY2022 | −185% |
| FY2023 | −13% |
| FY2024 | 27% |
| FY2025 | 31% |
Details›
- Gross margin12 months to Q2 2026
- 51%
- Operating margin12 months to Q2 2026
- 43%
- Net margin12 months to Q2 2026
- 21%
- Free cash flow margin
- 32%
- Revenue, trailing twelve months
- $847M
- Free cash flow, trailing twelve months
- $274M
- Net income, trailing twelve months
- $180M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.